Management of LBP With Radiculopathy.
Unknown statusNot applicableNCT04022798
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study is to determine the effectiveness of Neural mobilization(NM) technique compared with lumbar stabilization exercise (LSE) and Radial Extracorporeal Shock Wave Therapy (rESWT) in the physical therapy management of chronic low back pain (CLBP) with radiculopathy. Subjects will be randomly assigned into two groups. Group A (NM, LSE and rESWT) and Group B (LSE and rESWT).
Study details
- Official title
- Randomized Controlled Trial of Effectiveness of Neural Mobilization in the Management of Chronic Low Back Pain With Radiculopathy.
- Conditions
- Interventions
- Other: Exercise, manual therapy
- Sponsor
- University of Tabuk
- Start date
- 2019-07-01
- Primary completion
- 2019-10-30
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Saudi Arabia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Lower back pain should be Lower than 5 on the Visual Analogue Scale, * \> 18 years, * Not taken physical therapy treatment in the past 6 months period, * No previous surgery, such as structural anomalies, spinal cord compressions, severe instabilities, severe osteoporosis, acute infections, severe cardiovascular or metabolic diseases, * A body mass index less than 30kg/m2. Exclusion Criteria: * Pain with a score above 5 on the Visual Analogue Scale (VAS), * ≤ 18 years, * Had physical therapy treatment in the past 6 months period, * Had undergone previous surgery, such as structural anomalies, spinal cord compressions, severe instabilities, severe osteoporosis, acute infections, severe cardiovascular or metabolic diseases, * pregnant * A body mass index above 30kg/m2.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04022798